English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Systemic amyloidosis is caused by misfolding and aggregation of globular proteins  in vivo  for which effective treatments are urgently needed. Inhibition of protein self-aggregation represents an attractive therapeutic strategy. Studies on the amyloidogenic variant of β 2 -microglobulin, D76N, causing hereditary systemic amyloidosis, have become particularly relevant since fibrils are formed  in vitro  in physiologically relevant conditions. Here we compare the potency of two previously described inhibitors of wild type β 2 -microglobulin fibrillogenesis, doxycycline and single domain antibodies (nanobodies). The β 2 -microglobulin -binding nanobody, Nb24, more potently inhibits D76N β 2 -microglobulin fibrillogenesis than doxycycline with complete abrogation of fibril formation. In β 2 -microglobulin knock out mice, the D76N β 2 -microglobulin/ Nb24 pre-formed complex, is cleared from the circulation at the same rate as the uncomplexed protein; however, the analysis of tissue distribution reveals that the interaction with the antibody reduces the concentration of the variant protein in the heart but does not modify the tissue distribution of wild type β 2 -microglobulin. These findings strongly support the potential therapeutic use of this antibody in the treatment of systemic amyloidosis.

A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo